New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer
- 1 January 2012
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 64 (1) , 4-22
Abstract
Prostate cancer is the most commonly diagnosed cancer and second most common cause of cancer deaths in American men. Its long latency, slow progression, and high incidence rate make prostate cancer ideal for targeted chemopreventative therapies. Therefore, chemoprevention studies and clinical trials are essential for reducing the burden of prostate cancer on society. Epidemiological studies suggest that tea consumption has protective effects against a variety of human cancers, including that of the prostate. Laboratory and clinical studies have demonstrated that green tea components, specifically the green tea catechin (GTC) epigallocatechin gallate, can induce apoptosis, suppress progression, and inhibit invasion and metastasis of prostate cancer. Multiple mechanisms are involved in the chemoprevention of prostate cancer with GTCs; understanding and refining models of fundamental molecular pathways by which GTCs modulate prostate carcinogenesis is essential to apply the utilization of green tea for the chemoprevention of prostate cancer in clinical settings. The objective of this article is to review and summarize the most current literature focusing on the major mechanisms of GTC chemopreventative action on prostate cancer from laboratory, in vitro, and in vivo studies, and clinical chemoprevention trials.Keywords
This publication has 197 references indexed in Scilit:
- Tea and cancer prevention: Epidemiological studiesPharmacological Research, 2011
- Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat modelThe Journal of Nutritional Biochemistry, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Defining the pathway to insulin-like growth factor system targeting in cancerBiochemical Pharmacology, 2010
- Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cellsCancer Letters, 2009
- IGF-1 Receptor Inhibitors in Clinical Trials—Early LessonsJournal of Mammary Gland Biology and Neoplasia, 2008
- Green tea polyphenols as a natural tumour cell proteasome inhibitorInflammopharmacology, 2008
- Suppression of NFκB and its Regulated Gene Products by Oral Administration of Green Tea Polyphenols in an Autochthonous Mouse Prostate Cancer ModelPharmaceutical Research, 2008
- Tea polyphenols for health promotionLife Sciences, 2007
- Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancerMolecular Oncology, 2007